Wall Street's Winning Streak Pauses; Private Sector Hiring Slows
U.S. stock futures were trading
marginally lower ahead of Wednesday's open after a string of
record-setting days, weighed down by a weaker dollar and losses across
Europe. Selling pressure has been mitigated, however, by reports that
Fed governor Jerome Powell, one of the staunchest doves on the Fed
board, is favored by President Trump to replace Janet Yellen when her
term as Fed Chair expires in February.
Stocks remained defensive following private payroll data that indicated employers in the private sector added just 135,000 jobs in September, a much slower pace than the revised 228,000 number of jobs created in August.
Later this morning, Wall Street will get a look at activity in the services sector of the economy with the final September purchasing managers index (expected 55.2), and the Institute for Supply Management non-manufacturing index (expected 55.5).
In other news, the banking sector is losing ground in reaction to President Trump's remarks calling on Wall Street to forgive Puerto Rico's $70 billion public debt. During an interview Tuesday, the president said the island's debt will have to be "wiped out...owing a lot of money to Wall Street." Shares of Goldman Sachs ( GS ), JP Morgan ( JPM ) and Citigroup ( C ), are all trading lower.
-Dow Jones Industrial down 0.08%
-S&P 500 futures down 0.12%
-Nasdaq 100 futures down 0.20%
SENTIMENT
Nikkei up 0.06%
Hang Seng up 0.73%
Shanghai Composite closed
FTSE-100 down 0.08%
DAX-30 up 0.05%
PRE-MARKET SECTOR WATCH
(-) Large cap tech: Lower
(+/-) Chip stocks: Mixed
(-) Software stocks: Lower
(-) Hardware stocks: Lower
(+/-) Internet stocks: Mixed
(-) Oil stocks: Lower
(+/-) Biotech stocks: Mixed
(-) Drug stocks: Lower
(-) Financial stocks: Lower
(+/-) Retail stocks: Mixed
(+) Industrial stocks: Higher
(+) Airlines: Higher
(-) Autos: Lower
UPSIDE MOVERS:
(+) CATB (+29.68%) Reported positive results from phase 2 MoveDMD trial evaluating edasalonexent
(+) CTMX (+34.21%) Partnering with Amgen ( AMGN ) for strategic collaboration in immuno-oncology
(+) CAPR (+15.55%) Reported positive six-month results in Duchenne muscular dystrophy Hope clinical trial
(+) VKTX (+5.17%) Reported top-line results from proof-of-concept study of VK0214
DOWNSIDE MOVERS:
(-) TEVA (-11.80%) FDA approved competitor Mylan's ( MYL ) generic Copaxone
(-) ODP (-10.68%) Announced plans to acquire CompuCom for $1 billion
(-) RIGL (-8.98%) Offering $40 million in common shares
The views and opinions expressed
herein are the views and opinions of the author and do not necessarily
reflect those of Nasdaq, Inc.
Stocks remained defensive following private payroll data that indicated employers in the private sector added just 135,000 jobs in September, a much slower pace than the revised 228,000 number of jobs created in August.
Later this morning, Wall Street will get a look at activity in the services sector of the economy with the final September purchasing managers index (expected 55.2), and the Institute for Supply Management non-manufacturing index (expected 55.5).
In other news, the banking sector is losing ground in reaction to President Trump's remarks calling on Wall Street to forgive Puerto Rico's $70 billion public debt. During an interview Tuesday, the president said the island's debt will have to be "wiped out...owing a lot of money to Wall Street." Shares of Goldman Sachs ( GS ), JP Morgan ( JPM ) and Citigroup ( C ), are all trading lower.
-Dow Jones Industrial down 0.08%
-S&P 500 futures down 0.12%
-Nasdaq 100 futures down 0.20%
SENTIMENT
Nikkei up 0.06%
Hang Seng up 0.73%
Shanghai Composite closed
FTSE-100 down 0.08%
DAX-30 up 0.05%
PRE-MARKET SECTOR WATCH
(-) Large cap tech: Lower
(+/-) Chip stocks: Mixed
(-) Software stocks: Lower
(-) Hardware stocks: Lower
(+/-) Internet stocks: Mixed
(-) Oil stocks: Lower
(+/-) Biotech stocks: Mixed
(-) Drug stocks: Lower
(-) Financial stocks: Lower
(+/-) Retail stocks: Mixed
(+) Industrial stocks: Higher
(+) Airlines: Higher
(-) Autos: Lower
UPSIDE MOVERS:
(+) CATB (+29.68%) Reported positive results from phase 2 MoveDMD trial evaluating edasalonexent
(+) CTMX (+34.21%) Partnering with Amgen ( AMGN ) for strategic collaboration in immuno-oncology
(+) CAPR (+15.55%) Reported positive six-month results in Duchenne muscular dystrophy Hope clinical trial
(+) VKTX (+5.17%) Reported top-line results from proof-of-concept study of VK0214
DOWNSIDE MOVERS:
(-) TEVA (-11.80%) FDA approved competitor Mylan's ( MYL ) generic Copaxone
(-) ODP (-10.68%) Announced plans to acquire CompuCom for $1 billion
(-) RIGL (-8.98%) Offering $40 million in common shares
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Very detailed and useful information you have shared here. Market related Updates and trading calls are very important source of gaining idea about market performance. Because to earn well you need to have all the market updates. Many traders are taking services and tips likestock tips to get the investment ideas.
ReplyDelete